Skip to main content icon/video/no-internet

Assessment of psychopathology, including substance use disorder, plays an important role in the overall care of the client. Accurate and thorough assessment should enable the clinician to (a) reach a diagnosis of the client, (b) develop the client's case conceptualization and treatment plan, and (c) monitor treatment progress and treatment outcome. The overall goal for any assessment should be to better understand the specific disorder from which the client suffers. Assessment also provides a means for clinicians and researchers to share a common language in communicating about the client's diagnosis, case conceptualization, progress, and outcome.

Ideally, the assessment process provides the therapist and patient the opportunity to develop a facultative working relationship. For that reason, assessment is considered to mark the beginning of the therapeutic relationship. Assessment should also include an evaluation of the client's immediate and longer-term needs. Those needs should be reflected in the development and evaluation of treatment plans.

Pretreatment Assessment

The goals and objectives of the assessment process need to be well defined. In this regard, the Institute of Medicine (IOM) differentiated among three levels of assessment of substance use disorders: (1) screening, (2) problem assessment, and (3) personal assessment. In this listing, screening is the least comprehensive and, accordingly, the least expensive assessment, whereas personal assessment is the most comprehensive and the most costly. The goals of these three levels of assessment differ significantly.

Screening is designed to identify, quickly and inexpensively, individuals who may be at risk for a substance use disorder. This process is sometimes referred to as "case identification." Because substance use and abuse put people at risk for physical, psychological, legal, and social problems, it is important for primary health care professionals to identify individuals who are heavy users of alcohol and other drugs and to initiate early intervention. It is also the case that heavy substance use often interferes with efforts to treat mental, cognitive, and physical disorders, so substance use problems should be identified and evaluated even if the target disorder is not substance abuse.

Unfortunately, substance use disorders are still associated with social stigma, making it difficult for some clients to admit to a problem with alcohol or other drugs until or unless they have lost control over their alcohol or drug use. In addition, the heavy use of psychoactive substances can lead to memory problems, which makes it difficult for those afflicted to provide accurate information. Health care professionals need to be sensitive to these issues and ask about the use of alcohol, tobacco, over-the-counter drugs, and recreational drugs in as nonthreatening a way as possible.

Screening methods are often used in general medical settings, in emergency room settings, and in employee assistance programs. The aim of screening is to determine whether or not the client requires a more in-depth assessment for a substance use disorder, is in immediate need of medical detoxification or psychiatric treatment, or needs advice on how to cut down on the use or abuse of alcohol or other drugs. There are three ways to screen for psychoactive substance use and abuse: (1) laboratory tests, which are often used in medical settings (e.g., blood or urine analysis); (2) self-report screening methods, which are easy to administer, require minimal training, and are easy to incorporate into a comprehensive health assessment; and (3) brief screening interviews.

...

  • Loading...
locked icon

Sign in to access this content

Get a 30 day FREE TRIAL

  • Watch videos from a variety of sources bringing classroom topics to life
  • Read modern, diverse business cases
  • Explore hundreds of books and reference titles

Sage Recommends

We found other relevant content for you on other Sage platforms.

Loading